News Release
 
 
Investor Relations Contacts:
 
Sravan Emany
 
Senior Vice President, Strategy, Treasury & Investor Relations
 
(609) 936-2488
 
sravan.emany@integralife.com
 
 
 
Michael Beaulieu
 
Director, Investor Relations
 
(609) 750-2827
 
michael.beaulieu@integralife.com
 
 
Media Contact:
 
Laurene Isip
 
Senior Director, Global Corporate Communications
 
(609) 750-7984
 
laurene.isip@integralife.com
 

Integra LifeSciences Reports First Quarter 2019 Financial Results
Reported revenues amounted to $359.7 million; organic revenues increased 3.1%
GAAP and adjusted earnings per diluted share were $0.38 and $0.65, respectively
The Company reaffirms reported and organic revenue guidance for the full-year 2019


Plainsboro, New Jersey, April 24, 2019 -
Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today reported financial results for the first quarter ending March 31, 2019.
First Quarter 2019 Highlights
Reported revenues were $359.7 million, an increase of 0.7% compared to the first quarter of 2018, and organic revenues increased 3.1% over the first quarter of 2018;
Reported revenues in the Codman Specialty Surgical segment decreased (0.7)% compared to the first quarter of 2018;
Reported revenues in the Orthopedics and Tissue Technologies segment increased 3.4% compared to the first quarter of 2018;


The following information was filed by Integra Lifesciences Holdings Corp (IART) on Wednesday, April 24, 2019 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-Q Quarterly Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one quarter to another to evaluate Integra Lifesciences Holdings Corp's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Integra Lifesciences Holdings Corp.

Continue

Never Miss A New SEC Filing Again


Real-Time SEC Filing Notifications
Screenshot taken from Gmail for a new 10-K Annual Report
Last10K.com Member Feature

Receive an e-mail as soon as a company files an Annual Report, Quarterly Report or has new 8-K corporate news.

Continue

We Highlighted This SEC Filing For You


SEC Filing Sentiment Analysis - Bullish, Bearish, Neutral
Screenshot taken from Wynn's 2018 10-K Annual Report
Last10K.com Member Feature

Read positive and negative remarks made by management in their entirety without having to find them in a 10-K/Q.

Continue

Widen Your SEC Filing Reading Experience


Increased Reading Area for SEC Filings
Screenshot taken from Adobe Inc.'s 10-Q Quarterly Report
Last10K.com Member Feature

Remove data columns and navigations in order to see much more filing content and tables in one view

Continue

Uncover Actionable Information Inside SEC Filings


SEC Filing Disclosures
Screenshot taken from Lumber Liquidators 10-K Annual Report
Last10K.com Member Feature

Read both hidden opportunities and early signs of potential problems without having to find them in a 10-K/Q

Continue

Log in with your credentials

or    

Forgot your details?

Create Account